SpringWorks’ Ogsiveo Is First-Ever US FDA-Approved Drug For Desmoid Tumors

Nirogacestat Also In Anti-BCMA Combo, Ovarian Cancer Studies

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.